Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Vigil Neuroscience, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 52 | 2 | 51 | +1 |
| Shares | 27.7M | 4.26M | 22.6M | −855.5K (−3.6%) |
| Value | $94.2M | $14.5M | $38.4M | −$41.3M (−51.8%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Vigil Neuroscience, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 500,000 | $850.0K | 0.24% |
| Blair William & Co | 323,900 | $550.6K | 0.00% |
| Goldman Sachs Group Inc | 256,642 | $436.3K | 0.00% |
| Susquehanna International Group, LLP | 212,664 | $361.5K | 0.00% |
| Trustees of Columbia University in the City of New York | 192,973 | $328.1K | 0.05% |
| Boothbay Fund Management, LLC | 146,750 | $249.5K | 0.01% |
| Squarepoint Ops LLC | 113,596 | $193.1K | 0.00% |
| Jane Street Group, LLC | 48,812 | $83.0K | 0.00% |
| Acadian Asset Management LLC | 37,905 | $63.0K | 0.00% |
| Engineers Gate Manager LP | 13,695 | $23.3K | 0.00% |
| R Squared Ltd | 910 | $1.55K | 0.00% |
| BNP Paribas Arbitrage, SA | 228 | $388 | 0.00% |
Sold out (11)
Institutions that held Vigil Neuroscience, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Deep Track Capital, LP | 1,553,996 | $5.28M |
| StemPoint Capital LP | 743,719 | $2.53M |
| OrbiMed Advisors LLC | 448,891 | $1.53M |
| Walleye Capital LLC | 119,792 | $407.3K |
| Sherbrooke Park Advisers LLC | 26,329 | $89.5K |
| Jump Financial, LLC | 10,000 | $34.0K |
| Catalyst Funds Management Pty Ltd | 4,100 | $13.9K |
| FMR LLC | 2,086 | $7.09K |
| Royal Bank of Canada | 471 | $2.00K |
| Nisa Investment Advisors, LLC | 45 | $153 |
| Gotham Asset Management, LLC | 5,933 | – |
Not filed for Q4 2024 yet (2)
Institutions that held Vigil Neuroscience, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Northpond Ventures, LLC | 4,214,498 | $14.3M |
| PEAK6 Investments LLC | 41,486 | $141.1K |